Samsung Biologics
South Korean biotechnology company / From Wikipedia, the free encyclopedia
Samsung Biologics is a South Korean biotechnology company headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, it provides contract development and manufacturing (CDMO) services to the biopharmaceutical industry.
Quick Facts Company type, Traded as ...
Company type | Public |
---|---|
KRX: 207940 | |
Industry | Biopharmaceuticals |
Founded | 2011; 13 years ago (2011) |
Headquarters | , |
Area served | Worldwide |
Key people | John Rim, President and CEO[1] |
Owners |
|
Subsidiaries | Samsung Bioepis |
Korean name | |
Hangul | |
Revised Romanization | Samseong Baiorojikseu |
McCune–Reischauer | Samsŏng Paiorojiksŭ |
Website | www |
Close
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly and AstraZeneca.[2][3][4] Samsung Biologics also partnered with Moderna for fill-finish, packaging and labeling of its mRNA vaccine, Spikevax,[5] during the COVID-19 pandemic.[6]